30.61
前日終値:
$30.83
開ける:
$30.82
24時間の取引高:
6,752
Relative Volume:
0.27
時価総額:
$N/A
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-2.26%
1か月 パフォーマンス:
+1.60%
6か月 パフォーマンス:
+10.26%
1年 パフォーマンス:
+26.94%
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile
Compare OZEM vs VTI, SPY, IVV, VB, QQQ
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
OZEM
Roundhill Glp 1 Weight Loss Etf
|
30.61 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
350.63 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
711.69 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
714.96 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
280.63 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
657.55 | 124.43B | 0 | 0 | 0 | 0.00 |
Roundhill Glp 1 Weight Loss Etf (OZEM) 最新ニュース
3 Ways to Invest in the Growing GLP-1 Weight Loss Market - MarketBeat
Stock List: Research Stocks from Around the World - GuruFocus
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
OZEM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
OZEM Stock Price, News & Analysis - Stock Titan
Can You Buy Ozempic Stock in 2026? - The Motley Fool
FDA Approves NVO's Increased Wegovy Dosage: Broaden Your Portfolio With These Healthcare ETFs - Bitget
FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs - The Globe and Mail
Discipline and Rules-Based Execution in OZEM Response - Stock Traders Daily
Here are the quant ratings of OZEM’s top holdings amid Novo's selloff - MSN
OZEM stock: What the Ratings say (OZEM:NASDAQ) - Seeking Alpha
ETFs with Pfizer Inc. ( PFE ) Exposure - ETF Database
Behavioral Patterns of OZEM and Institutional Flows - Stock Traders Daily
Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Short Interest Up 47.1% in January - Defense World
How to Invest in GLP-1 Stocks in 2026 - The Motley Fool
(OZEM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook - The Globe and Mail
NVO Receives FDA Approval for MASH Therapy: ETFs Expected to Benefit - intellectia.ai
OZEM Vs. THNR: Which Is The Better ETF In The GLP-1 And Weight Loss Space? - Seeking Alpha
EXCLUSIVE: Trump 'Amplified' Several Investing Themes – ETF CEO Picks 3 Sectors Benefitting The Most - Benzinga
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All - MarketBeat
New Year, New Strategy: Navigating Weight Loss ETFs - ETF Database
Insiders Bullish on Certain Holdings of OZEM - Nasdaq
How Roundhill Etf Trust Glp-1 & Weight Loss Etf (OZEM) Affects Rotational Strategy Timing - Stock Traders Daily
The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug - The Globe and Mail
6 Top-Performing ETF Areas of Last Week - sharewise.com
(OZEM) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Best-Performing ETFs of November - TradingView — Track All Markets
Roundhill Glp-1 & Weight Loss ETF (OZEM) stock price, news, quote and history - Yahoo Finance UK
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView
Why (OZEM) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Why Is Roundhill Glp-1 & Weight Loss ETF (OZEM) Stock Up Today? - Meyka
Understanding Momentum Shifts in (OZEM) - news.stocktradersdaily.com
Roundhill Glp 1 Weight Loss Etf (OZEM) 財務データ
Roundhill Glp 1 Weight Loss Etf (OZEM) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):